Thompson SCI is commercializing a patented device based treatment for spinal cord injury (SCI). This is a patient population that currently has no clinically effective treatment options and represents a multi-billion dollar market. Our team of biomedical engineers and surgeons are completing the development of a system that integrates into current treatment practices to deliver a targeted therapy that inhibits biological responses that result in permanent neurological loss.
Thompson SCI is commercializing a patented device based therapy to preserve neurologic function in patients who suffer spinal cord injuries
2013 Gold Winner